| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 81, 3164-3167, Copyright © 1996 by Endocrine Society
ARTICLES |
O Jakobovitz, D Nass, L DeMarco, AJ Barbosa, FB Simoni, G Rechavi and E Friedman
Oncogenetics Unit, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Carcinoid tumors are neuroendocrine neoplasms that are encountered either sporadically or as part of a familial syndrome, most notably- multiple endocrine neoplasia type 1 (MEN1). The MEN1 gene localizes to chromosome 11 (11q13) and presumably functions as a tumor suppressor gene. The molecular mechanisms underlying carcinoid tumor development and their clonal composition remain largely unknown. To establish whether carcinoid tumors develop via a mechanism similar to other MEN1- associated tumors, and indirectly determine their clonal composition, we analyzed 36 sporadically occurring carcinoid tumors with 16 chromosome 11 microsatellite markers, mostly from around the MEN1 region for loss of heterozygosity (LOH). Twenty one tumors (58%) displayed LOH of at least three markers, five lost almost an entire allele and the rest displayed a discontinuous pattern. Similar, but less extensive analysis was also carried out for 10 additional carcinoid tumors from Brazil, 6 of the 10 showed LOH with at least one marker. Overall, 36 of 46 tumors (78%) displayed LOH. In addition, 20 of 46 (43%) tumors exhibited a pattern of genomic instability. Thus, the majority of sporadically occurring carcinoid tumors are monoclonal whose tumorigenesis involves inactivation of a tumor suppressor gene on chromosome 11 and DNA mismatch repair genes mutations.
This article has been cited by other articles:
![]() |
M. M. Hassan, A. Phan, D. Li, C. G. Dagohoy, C. Leary, and J. C. Yao Family History of Cancer and Associated Risk of Developing Neuroendocrine Tumors: A Case-Control Study Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 959 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Yao, J. X. Zhang, A. Rashid, S.-C. J. Yeung, J. Szklaruk, K. Hess, K. Xie, L. Ellis, J. L. Abbruzzese, and J. A. Ajani Clinical and In vitro Studies of Imatinib in Advanced Carcinoid Tumors Clin. Cancer Res., January 1, 2007; 13(1): 234 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Furlan, R. Cerutti, S. Uccella, S. La Rosa, E. Rigoli, A. Genasetti, and C. Capella Different Molecular Profiles Characterize Well-Differentiated Endocrine Tumors and Poorly Differentiated Endocrine Carcinomas of the Gastroenteropancreatic Tract Clin. Cancer Res., February 1, 2004; 10(3): 947 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kytola, A. Hoog, B. Nord, B. Cedermark, T. Frisk, C. Larsson, and M. Kjellman Comparative Genomic Hybridization Identifies Loss of 18q22-qter as an Early and Specific Event in Tumorigenesis of Midgut Carcinoids Am. J. Pathol., May 1, 2001; 158(5): 1803 - 1808. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Serrano, S. U. Goebel, P. L. Peghini, I. A. Lubensky, F. Gibril, and R. T. Jensen Alterations in the p16INK4a/CDKN2A Tumor Suppressor Gene in Gastrinomas J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4146 - 4156. [Abstract] [Full Text] |
||||
![]() |
J. Zhao, R. R. de Krijger, D. Meier, E.-J. M. Speel, P. Saremaslani, S. Muletta-Feurer, C. Matter, J. Roth, P. U. Heitz, and P. Komminoth Genomic Alterations in Well-Differentiated Gastrointestinal and Bronchial Neuroendocrine Tumors (Carcinoids) : Marked Differences Indicating Diversity in Molecular Pathogenesis Am. J. Pathol., November 1, 2000; 157(5): 1431 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Yu, R. T. Jensen, I. A. Lubensky, E. H. Mahlamaki, Y.-L. Zheng, A. M. Herr, and L. J. Ferrin Survey of Genetic Alterations in Gastrinomas Cancer Res., October 1, 2000; 60(19): 5536 - 5542. [Abstract] [Full Text] |
||||
![]() |
I. I. Wistuba, C. Behrens, A. K. Virmani, G. Mele, S. Milchgrub, L. Girard, J. W. Fondon III, H. R. Garner, B. McKay, F. Latif, et al. High Resolution Chromosome 3p Allelotyping of Human Lung Cancer and Preneoplastic/Preinvasive Bronchial Epithelium Reveals Multiple, Discontinuous Sites of 3p Allele Loss and Three Regions of Frequent Breakpoints Cancer Res., April 1, 2000; 60(7): 1949 - 1960. [Abstract] [Full Text] |
||||
![]() |
M. Sarquis, E. Friedman, W. L. Boson, R. S. Gomez, A. F. Dias, and L. De Marco Microsatellite Instability in Sporadic Parathyroid Adenoma J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 250 - 252. [Abstract] [Full Text] |
||||
![]() |
D. Babovic-Vuksanovic, C. L. Constantinou, J. Rubin, C. M. Rowland, D. J. Schaid, and P. S. Karnes Familial Occurrence of Carcinoid Tumors and Association with Other Malignant Neoplasms Cancer Epidemiol. Biomarkers Prev., August 1, 1999; 8(8): 715 - 719. [Abstract] [Full Text] |
||||
![]() |
M. S. Turker, B. M. Gage, J. A. Rose, D. Elroy, O. N. Ponomareva, P. J. Stambrook, and J. A. Tischfield A Novel Signature Mutation for Oxidative Damage Resembles a Mutational Pattern Found Commonly in Human Cancers Cancer Res., April 1, 1999; 59(8): 1837 - 1839. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gortz, J. Roth, A. Krahenmann, R. R. de Krijger, S. Muletta-Feurer, K. Rutimann, P. Saremaslani, E. J. M. Speel, P. U. Heitz, and P. Komminoth Mutations and Allelic Deletions of the MEN1 Gene Are Associated with a Subset of Sporadic Endocrine Pancreatic and Neuroendocrine Tumors and Not Restricted to Foregut Neoplasms Am. J. Pathol., February 1, 1999; 154(2): 429 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Walch, H. F. Zitzelsberger, M. M. Aubele, A. E. Mattis, M. Bauchinger, S. Candidus, H. W. Prauer, M. Werner, and H. Hofler Typical and Atypical Carcinoid Tumors of the Lung Are Characterized by 11q Deletions as Detected by Comparative Genomic Hybridization Am. J. Pathol., October 1, 1998; 153(4): 1089 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shimon and S. Melmed Pituitary Tumor Pathogenesis J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1675 - 1681. [Full Text] [PDF] |
||||
![]() |
Q. Dong, L. V. Debelenko, S. C. Chandrasekharappa, M. R. Emmert-Buck, Z. Zhuang, S. C. Guru, P. Manickam, M. Skarulis, I. A. Lubensky, L. A. Liotta, et al. Loss of Heterozygosity at 11q13: Analysis of Pituitary Tumors, Lung Carcinoids, Lipomas, and Other Uncommon Tumors in Subjects with Familial Multiple Endocrine Neoplasia Type 1 J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1416 - 1420. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |